FYI ...

5%

Increase in minimally invasive cosmetic procedures from 2009
to 2010

Source: American Society of Plastic Surgeons

Connect to Us

Digital Edition

Epicyn gel wins derm indication

Washington — The Food and Drug Administration has approved Epicyn HydroGel (Oculus Innovative Sciences) for treatment of various dermatoses and burns, MedPage Today reports.
Read full article.

Galderma ups ante in Q-Med bid

Lausanne, Switzerland — Galderma, the L’Oréal/Nestlé joint venture based here, has received the necessary regulatory approvals in its bid for Swedish medical device firm Q-Med, the New York Times reports. Read full article.

Immune protein promotes skin cancer

Washington — An unexpected immune protein exacerbates cancer due to sun exposure, and a drug designed to block the protein might halt tumor growth, a recently published study suggests. Read full article.

Biovail buys Canada rights to Aczone

Mississauga, Ontario — Biovail Laboratories, a subsidiary of Valeant Pharmaceuticals International, based here, has secured the Canadian distribution rights to Aczone, an acne treatment medication owned by Allergan, according news reports. Read full article.

Career Opportunities

Arizona Skin & Laser	Louisiana State University Health Science
Dartmouth Hitchcock Med Ctr	New York Dermatology Group (Urologists Needed_Manhattan Private Practice)
David A. High	Orbital and Oculofacial Consultants
Greenville Hospital System	Philip Bruder MD

Contact Us

Contact a Dermatology Times editor Click Here
Contact a Dermatology Times sales representative Click Here
Learn about direct mail, reprints and classifieds in Dermatology Times Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.